Next-generation multiplex-edited CAR-NK cells: more edits, more power?

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Allogeneic natural killer (NK) cells are promising for "off-the-shelf" chimeric antigen receptor (CAR)-immune cell therapy.
• Reduced NK cell persistence and inactivation by immunosuppressive factors limit current CAR-NK cell therapy efficacy.

Purpose of the Study:

• To optimize the intrinsic functionality of CAR-NK cells using multiplex CRISPR base editing.
• To enhance the therapeutic potential and potency of CAR-NK cells for cancer immunotherapy.

Main Methods:

• Multiplex CRISPR base editing was employed to modify multiple sites in NK cells simultaneously, avoiding double-stranded DNA breaks.
• A non-viral, single electroporation method was used to integrate CAR transgenes and edit immune checkpoints in NK cells.
• In vitro assays and xenograft mouse models were utilized to assess the potency and safety of edited CAR-NK cells.

Main Results:

• CRISPR base editing efficiently modified up to six sites in NK cells, enhancing their functionality.
• CAR-NK cells with up to three base edits exhibited improved in vitro potency compared to unedited cells.
• In vivo studies in mouse models demonstrated increased CAR-NK cell potency but also revealed potential organ toxicity.

Conclusions:

• CRISPR base editing is a powerful tool for enhancing the cytotoxic potential of CAR-NK cells.
• The study highlights the therapeutic promise of base-edited CAR-NK cells for off-the-shelf applications.
• Further research is necessary to address observed organ toxicity and ensure the safety of CAR-NK cell therapy before clinical translation.